In the fourth quarter, the Emerging Markets Equity Portfolio retreated in absolute terms and underperformed its benchmark, ...

If approved, TLX250-CDx will become the first commercially available imaging agent to accurately and non-invasively diagnose and characterize clear cell renal cell carcinoma (ccRCC), the most common ...

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in ...

Illumina, Inc. ILMN recently entered into a collaboration with Broad Clinical Labs to rapidly streamline and scale single-cell projects with cutting-edge tools and workflows. Together, the companies ...

The Cheltenham Gold Cup is the most prestigious race of the British and Irish jump racing season and the centrepiece of the ...

With A$AP Rocky’s Ray-Ban moments, courtroom style has become a cultural phenomenon, blending law, fashion, and branding into ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Three of Australia's most successful global life sciences plays have reported increased interim profits – with the promise of ...

Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.

The first of Opthea’s (ASX:OPT) two phase III eye disease trials has hit a key development milestone, with the last patient ...

Mayor Randall Woodfin told the Birmingham City Council Tuesday that murder trials in Jefferson County are taking up to three years to reach the courtroom. Without additional resources, he warned, that ...

The grey market premium indicates an estimated listing price of ₹114, reflecting a potential gain of 21.28%. Royalarc Electrodes’ IPO, opened on February 14, has seen a sluggish response with ...